Skip to main content
Premium Trial:

Request an Annual Quote

Weizmann's GeneCards Upgraded to Version 2.8

Premium

REHOVOT, Israel--The Weizmann Institute of Science's Genome Center and Bioinformatics Unit announced the release of version 2.8 of GeneCards last month. The database that catalogs human genes, their products, and their involvement in diseases was developed by Weizmann researchers Michael Rebhan, Liora Yaar, Vered Chalifa-Caspi, Marilyn Safran, Hershel Safer, Jaime Prilusky, and Doron Lancet. It offers information about the functions of all human genes with an approved symbol, as well as selected others. The database, featuring a navigation support system that guides users to information, is especially useful for those who are searching for information about large sets of genes or proteins, including scientists working in functional genomics and proteomics, according to the institute. Version 2.8 includes data for 8,100 human genes.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.